{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:52:45Z","timestamp":1792788765646,"version":"4.5.0"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Federfarma Piemonte"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0229842","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T13:33:25Z","timestamp":1584538405000},"page":"e0229842","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Opportunistic screening for type 2 diabetes in community pharmacies. Results from a region-wide experience in Italy"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1919-2199","authenticated-orcid":true,"given":"Roberto","family":"Gnavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Sciannameo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Baratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Scarinzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Parente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Mana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Giaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Cavallo Perin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Spadea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Brusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"key":"pone.0229842.ref001","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.numecd.2017.12.004","article-title":"Prevalence of and secular trends in diagnosed diabetes in Italy: 1980\u20132013","volume":"28","author":"R Gnavi","year":"2018","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"pone.0229842.ref002","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(17)30058-2","article-title":"Type 2 diabetes","volume":"309","author":"S Chatterjee","year":"2017","journal-title":"Lancet"},{"key":"pone.0229842.ref003","doi-asserted-by":"crossref","first-page":"e010155","DOI":"10.1136\/bmjopen-2015-010155","article-title":"Social inequalities in prevalence of diagnosed and undiagnosed diabetes and impaired glucose regulation in participants in the Health Surveys for England series","volume":"6","author":"A Moody","year":"2016","journal-title":"BMJ Open"},{"key":"pone.0229842.ref004","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00125-011-2441-9","article-title":"How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? Twelve year follow-up of the Ely cohort","volume":"55","author":"M Rahman","year":"2012","journal-title":"Diabetologia"},{"key":"pone.0229842.ref005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17350","article-title":"Screening for type 2 diabetes: a short report for the National Screening Committee","volume":"17","author":"NR Waugh","year":"2013","journal-title":"Health Technol Assess"},{"key":"pone.0229842.ref006","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2337\/diacare.26.3.725","article-title":"The diabetes risk score. A practical tool to predict type 2 diabetes risk","volume":"26","author":"J Lindstrom","year":"2003","journal-title":"Diabetes Care"},{"key":"pone.0229842.ref007","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2337\/diacare.28.5.1187","article-title":"Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study","volume":"28","author":"M Franciosi","year":"2005","journal-title":"Diabetes Care"},{"key":"pone.0229842.ref008","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1715163517745517","article-title":"Pharmacists as accessible primary health care providers: Review of the evidence","volume":"151","author":"RT Tsuyuki","year":"2018","journal-title":"Can Pharm J"},{"issue":"4","key":"pone.0229842.ref009","first-page":"168","article-title":"La Farmacia dei Servizi: verso un nuovo modello per la prevenzione delle patologie croniche","volume":"108","author":"T Spadea","year":"2017","journal-title":"Recenti Prog Med"},{"key":"pone.0229842.ref010","unstructured":"Eurostat,https:\/\/ec.europa.eu\/eurostat\/cache\/metadata\/Annexes\/educ_uoe_h_esms_an2.htm [Accessed 5 December 2019]."},{"key":"pone.0229842.ref011","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.2337\/diabetes.53.7.1782","article-title":"Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study","volume":"53","author":"E Bonora","year":"2004","journal-title":"Diabetes"},{"key":"pone.0229842.ref012","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1475-2840-6-5","article-title":"Monitoring the occurrence of diabetes mellitus and its major complications: the combined use of different administrative databases","volume":"6","author":"S Brocco","year":"2007","journal-title":"Cardiovasc Diabetol"},{"key":"pone.0229842.ref013","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1464-5491.2007.02068.x","article-title":"Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990\u20132000","volume":"24","author":"NG Forouhi","year":"2007","journal-title":"Diabet Med"},{"key":"pone.0229842.ref014","doi-asserted-by":"crossref","first-page":"e017725","DOI":"10.1136\/bmjopen-2017-017725","article-title":"Pharmacy Diabetes Screening Trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacy","volume":"7","author":"I Krass","year":"2017","journal-title":"BMJ Open"},{"key":"pone.0229842.ref015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11096-006-9034-6","article-title":"Sequential screening for diabetes\u2014Evaluation of a campaign in Swiss community pharmacies","volume":"28","author":"KE Hersberger","year":"2006","journal-title":"Pharm World Sci"},{"key":"pone.0229842.ref016","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1186\/1471-2458-14-487","article-title":"Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study","volume":"14","author":"MA Via-Sosa","year":"2014","journal-title":"BMC Public Health"},{"key":"pone.0229842.ref017","first-page":"387","article-title":"Detection of people at risk of diabetes in community pharmacies of Pontevedra (Spain) (DEDIPO)","volume":"63","author":"JA Fornos-P\u00e9rez","year":"2016","journal-title":"Endocrinol Nutr"},{"key":"pone.0229842.ref018","article-title":"Community pharmacies offer a potential high-yeld and convenient arena for total cholesterol and CVD risk screening","author":"K Svendsen","year":"2018","journal-title":"Eur J Publ Health"},{"key":"pone.0229842.ref019","doi-asserted-by":"crossref","first-page":"e91157","DOI":"10.1371\/journal.pone.0091157","article-title":"The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting","volume":"9","author":"A Willis","year":"2014","journal-title":"PLoS One"},{"key":"pone.0229842.ref020","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/eurpub\/cky009","article-title":"Detecting persons at risk for diabetes mellitus type 2 using FINDRISC: results from a community pharmacy-based study","volume":"28","author":"S Milovanovic","year":"2018","journal-title":"Eur J Public Health"},{"key":"pone.0229842.ref021","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/bmj.317.7154.307","article-title":"Number needed to screen: development of a statistic for disease screening","volume":"317","author":"CM Rembold","year":"1998","journal-title":"BMJ"},{"key":"pone.0229842.ref022","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/1471-2458-10-506","article-title":"The effectiveness and efficiency of diabetes screening in Ontario, Canada: a population-based cohort study","volume":"10","author":"SE Wilson","year":"2010","journal-title":"BMC Public Health"},{"key":"pone.0229842.ref023","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00038-018-1076-8","article-title":"The contribution of behavioural and metabolic risk factors to socioeconomic inequalities in mortality: the Italian Longitudinal Study","volume":"63","author":"C Piccinelli","year":"2018","journal-title":"Int J Public Health"},{"issue":"6","key":"pone.0229842.ref024","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.gaceta.2013.03.002","article-title":"Socioeconomic inequalities in the incidence and prevalence of type 2 diabetes mellitus in Europe","volume":"27","author":"A Espelt","year":"2013","journal-title":"Gac Sanit"},{"issue":"10","key":"pone.0229842.ref025","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.numecd.2007.11.004","article-title":"Socio-economic differences in the prevalence of diabetes in Italy: The population-based Turin study","volume":"18","author":"R Gnavi","year":"2008","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"pone.0229842.ref026","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/eurpub\/ckt119","article-title":"Does breast cancer screening level health inequalities out? A population-based study in an Italian region","volume":"24","author":"B Pacelli","year":"2014","journal-title":"Eur J Public Health"},{"key":"pone.0229842.ref027","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/CEJ.0000000000000211","article-title":"Absence of socioeconomic inequalities in access to good-quality breast cancer treatment within a population-wide screening programme in Turin (Italy)","volume":"25","author":"N Zengarini","year":"2016","journal-title":"Eur J Cancer Prev"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229842","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T13:33:35Z","timestamp":1584538415000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229842"}},"subtitle":[],"editor":[{"given":"Wen-Jun","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0229842","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,18]]}}}